The novel GLP-1 analogue liraglutide lowered plaque formation, protected memory and synaptic plasticity, and reduced inflammation in the brains of a mouse model of Alzheimer disease [16]. Here, GLP1R is linked to early-onset autosomal dominant Alzheimer disease.